Blufstein et al., 2018 - Google Patents
Human periodontal ligament cells exhibit no endotoxin tolerance upon stimulation with Porphyromonas gingivalis lipopolysaccharideBlufstein et al., 2018
View PDF- Document ID
- 7789125263615623568
- Author
- Blufstein A
- Behm C
- Nguyen P
- Rausch‐Fan X
- Andrukhov O
- Publication year
- Publication venue
- Journal of Periodontal Research
External Links
Snippet
Background/Objectives Endotoxin tolerance is characterized by a state of hyporesponsiveness after confrontation with endotoxins such as lipopolysaccharides (LPS) at low concentrations. The aim of this study was to investigate, whether pretreatment with …
- 239000002158 endotoxin 0 title abstract description 162
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—G01N2333/4701
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Blufstein et al. | Human periodontal ligament cells exhibit no endotoxin tolerance upon stimulation with Porphyromonas gingivalis lipopolysaccharide | |
Wara‐aswapati et al. | RANKL upregulation associated with periodontitis and Porphyromonas gingivalis | |
Tofiño-Vian et al. | Extracellular vesicles from adipose‐derived mesenchymal stem cells downregulate senescence features in osteoarthritic osteoblasts | |
Zhao et al. | Wnt5a promotes inflammatory responses via nuclear factor κB (NF-κB) and mitogen-activated protein kinase (MAPK) pathways in human dental pulp cells | |
Farez et al. | Toll-like receptor 2 and poly (ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE | |
Epron et al. | Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling | |
Fukada et al. | Factors involved in the T helper type 1 and type 2 cell commitment and osteoclast regulation in inflammatory apical diseases | |
Andrukhov et al. | Soluble CD14 enhances the response of periodontal ligament stem cells to P. gingivalis lipopolysaccharide | |
Lu et al. | NLRP 3 inflammasome may regulate inflammatory response of human periodontal ligament fibroblasts in an apoptosis‐associated speck‐like protein containing a CARD (ASC)‐dependent manner | |
Andrukhov et al. | Response of human periodontal ligament stem cells to IFN-γ and TLR-agonists | |
Richert et al. | A critical analysis of research methods and experimental models to study pulpitis | |
Chatzivasileiou et al. | Dental follicle progenitor cells responses to P orphyromonas gingivalis LPS | |
Nokhbehsaim et al. | Effects of enamel matrix derivative on periodontal wound healing in an inflammatory environment in vitro | |
Marshall et al. | Proteomic mapping of proteins released during necrosis and apoptosis from cultured neonatal cardiac myocytes | |
Behm et al. | Response of human mesenchymal stromal cells from periodontal tissue to LPS depends on the purity but not on the LPS source | |
Behm et al. | Soluble CD14 enhances the response of periodontal ligament stem cells to toll‐like receptor 2 agonists | |
Kim et al. | Aggregatibacter actinomycetemcomitans‐induced AIM2 inflammasome activation is suppressed by xylitol in differentiated THP‐1 macrophages | |
Varanat et al. | Activation of the TREM‐1 pathway in human monocytes by periodontal pathogens and oral commensal bacteria | |
Zhang et al. | Long non‐coding RNA lnc‐DC in dendritic cells regulates trophoblast invasion via p‐STAT3‐mediated TIMP/MMP expression | |
Domon et al. | Age‐related alterations in gene expression of gingival fibroblasts stimulated with P orphyromonas gingivalis | |
Lappin et al. | The influence of glycated hemoglobin on the cross susceptibility between type 1 diabetes mellitus and periodontal disease | |
Ohno et al. | Angiopoietin-like protein 2 regulates Porphyromonas gingivalis lipopolysaccharide-induced inflammatory response in human gingival epithelial cells | |
Song et al. | Filifactor alocis‐derived extracellular vesicles inhibit osteogenesis through TLR2 signaling | |
Gualtero et al. | Rosuvastatin inhibits interleukin (IL)‐8 and IL‐6 production in human coronary artery endothelial cells stimulated with Aggregatibacter actinomycetemcomitans serotype b | |
Guo et al. | CD24 activates the NLRP3 inflammasome through c‐Src kinase activity in a model of the lining epithelium of inflamed periodontal tissues |